Where does Chemours's income statement data come from?

Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Chemours CC Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$5.82B+0.5%	$5.81B+0.4%	$5.84B+0.8%	$5.85B+1.1%	$5.79B-1.7%
Total cost of revenue	$4.94B+5.3%	$4.91B+5.7%	$4.83B+3.6%	$4.79B+2.6%	$4.69B+0.5%
Gross profit	$878M-19.8%	$902M-21.1%	$1.01B-10.7%	$1.07B-4.9%	$1.1B-10.4%
Gross margin	15.1%-3.8pp	15.5%-4.2pp	17.3%-2.2pp	18.2%-1.2pp	18.9%-1.8pp
Research and development	$107M-0.9%	$108M-0.9%	$107M-1.8%	$110M+1.9%	$108M-1.8%
Selling, general and administrative	$823M+40.9%	$799M+33.6%	$839M+29.7%	$854M+26.5%	$584M-55.1%
Depreciation and amortization	$331M+7.1%	$340M+16.4%	$333M+13.3%	$326M+9.8%	$309M+2.7%
Total operating expenses	$969M+15.8%	$966M+17.4%	$1.01B+15.2%	$1.12B+21.1%	$837M-46.0%
Interest expense	$272M+1.9%	$269M+1.9%	$268M+3.1%	$268M+8.5%	$267M+16.6%
Other income (expense), net	$43M—	$26M—	——	——	——
Income from equity method investments	$34M-12.8%	$34M-22.7%	$35M-16.7%	$37M-15.9%	$39M-15.2%
Gain (loss) on extinguishment of debt	——	——	——	——	-$750K—
Income before income taxes	-$299M-887%	-$277M-356%	-$209M-681%	-$279M-444%	$38M+109%
Income tax expense	——	——	$140M+1,177%	$148M+1,333%	$26M+133%
Net income	-$410M-3,517%	-$386M-644%	-$350M-647%	-$428M-496%	$12M+104%
Net margin	-7%-7.3pp	-6.6%-7.9pp	-6%-7.1pp	-7.3%-9.2pp	0.2%+5.8pp
Diluted earnings per share	-$2.72-4,633%	-$2.56-669%	-$2.33-668%	-$2.86-503%	$0.06+103%
Basic earnings per share	-$2.72-3,986%	-$2.56-657%	-$2.33-655%	-$2.86-497%	$0.07+103%
Amortization Of Financing Costs And Discounts	$11M-8.3%	$11M-8.3%	$12M0.0%	$12M+9.1%	$12M+20.0%
Capital investments accrued but not yet paid	$34M—	$33M—	——	——	——
Deferred and other income taxes	——	——	——	$79M+191%	-$47M+67.4%
Gain (Loss) on Disposition of Assets	——	——	——	——	——
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	——	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$88M—	-$126M—	——	——	——
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$164M+51.5%	-$206M+41.6%	-$270M+28.2%	-$310M—	-$338M—
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$332M—	$264M—	——	——	——
Other income, net (Note 6)	$43M—	$26M—	——	——	——
All other operating activities	——	——	——	——	——
Payments of Debt Issuance Costs	——	——	——	——	——
Payments to Acquire Property, Plant, and Equipment	$178M-48.0%	$213M-40.8%	$277M-28.2%	$312M-21.2%	$342M-10.2%
Proceeds from disposition of property, plant and equipment/other	——	——	——	——	——
Restructuring Charges Asset Related And Other Charges	$39M-56.2%	$59M-1.7%	$63M-1.6%	$104M-28.3%	$89M-36.9%
Revenue From Contract With Customer Excluding Assessed Tax	$5.82B+0.5%	$5.81B+0.4%	$5.84B+0.8%	$5.85B+1.1%	$5.79B-1.7%
EBIT	-$27M-109%	-$8M-102%	$59M-80.1%	-$11M-103%	$305M+259%
EBITDA	$304M-50.5%	$332M-50.0%	$392M-33.6%	$315M-49.6%	$614M+463%
EBITDA	$304M-50.5%	$332M-50.0%	$392M-33.6%	$315M-49.6%	$614M+463%
EBITDA margin	5.2%-5.4pp	5.7%-5.8pp	6.7%-3.5pp	5.4%-5.4pp	10.6%+8.8pp
EBIT	-$27M-109%	-$8M-102%	$59M-80.1%	-$11M-103%	$305M+259%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Chemours's income statement data come from?: Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.